We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.01%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.93B
AUM Growth
+$1.86B
Cap. Flow
+$1.22B
Cap. Flow %
31.06%
Top 10 Hldgs %
44.77%
Holding
2,316
New
544
Increased
345
Reduced
243
Closed
1,102

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$208M
2
TSLA icon
Tesla
TSLA
+$33.2M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$28M
4
BHF icon
Brighthouse Financial
BHF
+$18.6M
5
GLD icon
SPDR Gold Trust
GLD
+$17.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 9.72%
2 Technology 5.35%
3 Industrials 3.23%
4 Financials 2.61%
5 Communication Services 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSW
2251
DELISTED
Advanced Disposal Services Inc
ADSW
-200,338
Closed -$6.06M
LVGO
2252
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-32,120
Closed -$4.5M
HTZ
2253
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
-349,800
Closed -$388K
HTZ
2254
DELISTED
Hertz Global Holdings, Inc.
HTZ
-397,342
Closed -$441K
HTZ
2255
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
-54,300
Closed -$60K
IMMU
2256
DELISTED
Immunomedics Inc
IMMU
-133,613
Closed -$11.4M
AXAS
2257
DELISTED
Abraxas Petroleum Corp
AXAS
-60
Closed
RST
2258
DELISTED
ROSETTA STONE INC
RST
-73,050
Closed -$2.19M
AIMT
2259
CALL
DELISTED
Aimmune Therapeutics
AIMT
-7,200
Closed -$248K
AIMT
2260
DELISTED
Aimmune Therapeutics
AIMT
-219,893
Closed -$7.58M
AIMT
2261
PUT
DELISTED
Aimmune Therapeutics
AIMT
-6,100
Closed -$210K
CETV
2262
CALL
DELISTED
Central European Media Enterprises Ltd
CETV
-11,600
Closed -$49K
CETV
2263
DELISTED
Central European Media Enterprises Ltd
CETV
-129,646
Closed -$543K
AKCA
2264
CALL
DELISTED
Akcea Therapeutics Inc
AKCA
-100
Closed -$2K
AKCA
2265
DELISTED
Akcea Therapeutics Inc
AKCA
-30,618
Closed -$555K
AKCA
2266
PUT
DELISTED
Akcea Therapeutics Inc
AKCA
-200
Closed -$4K
MNK
2267
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-2,000
Closed -$2K
MNK
2268
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-25,000
Closed -$24K
CCXX.WS
2269
DELISTED
Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex
CCXX.WS
-53,149
Closed -$106K
VSLR
2270
DELISTED
VIVINT SOLAR, INC.
VSLR
-46,399
Closed -$1.97M
AMTD
2271
DELISTED
TD Ameritrade Holding Corp
AMTD
-28,699
Closed -$1.12M
NBL
2272
DELISTED
Noble Energy, Inc.
NBL
-32,100
Closed -$274K
ETFC
2273
DELISTED
E*Trade Financial Corporation
ETFC
-44,050
Closed -$2.21M
DLPH
2274
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
-11,900
Closed -$199K
INWK
2275
CALL
DELISTED
InnerWorkings, Inc.
INWK
-200
Closed -$1K

Similar funds

Prelude Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Prelude Capital Management held 2,316 positions worth $3.93B, up 90% from $2.07B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prelude Capital Management deployed $1.22B of net new capital in Q4 2020, opening 544 new positions and adding to 345 existing holdings. Its largest new stake was Tesla: 194,520 shares worth $45.8M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 9.7% of assets, up from 4.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $6.78M trimmed.

  • Prelude Capital Management's largest Q4 2020 buy was Tesla: 194,520 shares worth $45.8M.
  • Prelude Capital Management added most to Amazon in Q4 2020, an estimated $208M increase.
  • Prelude Capital Management's biggest Q4 2020 reduction was Alibaba, cutting an estimated $6.78M.
  • Prelude Capital Management fully exited iShares 0-5 Year High Yield Corporate Bond ETF in Q4 2020, selling an estimated $24.2M.
  • Prelude Capital Management's ten largest holdings make up 45% of its $3.93B portfolio in Q4 2020.
  • Prelude Capital Management opened 544 new positions and closed 1,102 in Q4 2020.
  • Prelude Capital Management's portfolio value rose 90% quarter-over-quarter to $3.93B.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.